Financialsexperimental
MARIMED INC. (MRMD). Every figure is as filed in the company's 10-Q and 10-K reports. Quarters a filing does not report on their own are worked out from its year-to-date figures and marked *.
USD in thousands · shares in thousands · per-share amounts in USD
| Income Statement | Q2 FY26 30 Jun 2026 | Q1 FY26 31 Mar 2026 | Q4 FY25 31 Dec 2025 | Q3 FY25 30 Sept 2025 | Q2 FY25 30 Jun 2025 | Q1 FY25 31 Mar 2025 | Q4 FY24 31 Dec 2024 | Q3 FY24 30 Sept 2024 | Q2 FY24 30 Jun 2024 | Q1 FY24 31 Mar 2024 | Q4 FY23 31 Dec 2023 | Q3 FY23 30 Sept 2023 | Q2 FY23 30 Jun 2023 | Q1 FY23 31 Mar 2023 | Q4 FY22 31 Dec 2022 | Q3 FY22 30 Sept 2022 | Q2 FY22 30 Jun 2022 | Q1 FY22 31 Mar 2022 | Q4 FY21 31 Dec 2021 | Q3 FY21 30 Sept 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 33,208,060 | |||||||||||||||||||
| Revenue | 41,925 | 39,481 | 41,650* | 40,764 | 39,611 | 37,955 | 39,002* | 40,591 | 40,438 | 37,933 | 38,899* | 38,800 | 36,519 | 34,380 | 35,830* | 33,912 | 32,986 | 31,282 | ||
| Cost of revenue | 25,700 | 24,205 | 31,148* | 24,401 | 23,579 | 22,817 | 26,293* | 23,813 | 23,529 | 21,461 | 21,582* | 21,962 | 20,143 | 18,992 | 20,018* | 17,748 | 17,981 | 14,306 | 15,553.6* | 15,027.5 |
| Gross profit | 16,225 | 15,276 | 10,502* | 16,363 | 16,032 | 15,138 | 12,709* | 16,778 | 16,909 | 16,472 | 17,317* | 16,838 | 16,376 | 15,388 | 15,812* | 16,164 | 15,005 | 16,976 | 15,490.3* | 18,180.5 |
| Personnel | 1,481,350 | |||||||||||||||||||
| Personnel | 7,475 | 7,254 | 6,754* | 7,028 | 7,392 | 7,341 | 6,381* | 7,255 | 6,958 | 6,465 | 6,421* | 5,916 | 5,619 | 4,656 | 4,234* | 3,746 | 3,382 | 3,042 | ||
| Marketing and promotion | 847 | 765 | 1,166* | 1,121 | 761 | 898 | 1,218* | 1,828 | 1,856 | 1,762 | 1,580* | 1,585 | 1,666 | 1,146 | 882* | 1,402 | 809 | 643 | 567.2* | 563.2 |
| General and administrative | 6,864 | 6,887 | 6,957* | 6,592 | 6,343 | 6,250 | 6,574* | 6,100 | 6,804 | 6,140 | 6,612* | 6,135 | 5,080 | 4,305 | 3,845* | 5,097 | 5,565 | 6,228 | 10,626.9* | 9,481 |
| Acquisition-related and other | 116 | 169 | 90* | 145 | 139 | 112 | 146* | 371 | 350 | 84 | 48* | 32 | 425 | 190 | 64* | 143 | 754 | |||
| Bad debt | 505 | 76 | 60* | -122 | 256 | 1,388 | -205* | -116 | -15 | 0 | 245* | -122 | 39 | -44 | 3,698* | 40 | 0* | 14 | 7.5* | 35.6 |
| Total operating expenses | 15,807 | 15,151 | 15,027* | 14,764 | 14,891 | 15,989 | 14,114* | 15,438 | 15,953 | 14,451 | 14,906* | 13,546 | 12,829 | 10,253 | 12,723* | 10,428 | 10,510 | 9,927 | 14,286.3* | 11,561.2 |
| Income from operations | 418 | 125 | -4,525* | 1,599 | 1,141 | -851 | -1,405* | 1,340 | 956 | 2,021 | 2,411* | 3,292 | 3,547 | 5,135 | 3,089* | 5,736 | 4,495 | 7,049 | 1,203.9* | 6,619.4 |
| Interest expense | -1,629 | -1,558* | -2,482 | -2,640 | -2,505 | -422* | -518 | -440 | -313 | -279.3* | -300 | |||||||||
| Interest expense | -2,007 | -1,976 | -2,153* | -1,825 | -1,762 | -1,762 | -1,886* | -1,705 | -1,724 | |||||||||||
| Interest income | 36 | 36 | 103* | 25 | 25 | 24 | 38* | 25 | 25 | 26 | 27* | 29 | 115 | 99 | 239* | 239 | 318 | 163 | 12.7* | 25.7 |
| Loss on obligations settled with equity | -0* | |||||||||||||||||||
| Gain (loss) on change in fair value of investment | 48 | -169.2* | -522.1 | |||||||||||||||||
| Gain on extinguishment of debt | 0 | 699 | ||||||||||||||||||
| Other income, net | 0 | -753* | 19 | 17 | 0 | 0* | 0 | -30 | -20 | -79* | -646 | -10 | -900 | -151* | -251 | -727 | 0* | 309.2 | ||
| Other investment income | 954 | |||||||||||||||||||
| Total interest and other expense, net | -1,971 | -1,241 | -2,803* | -1,781 | -1,720 | -1,738 | -1,848* | -1,680 | -1,729 | -1,623 | -12,041* | -3,099 | -2,535 | -3,306 | -334* | -530 | -849 | 852 | -435.8* | -487.1 |
| Loss before income taxes | -1,553 | -1,116 | -7,328* | -182 | -579 | -2,589 | -3,253* | -340 | -773 | 398 | -9,630* | 193 | 1,012 | 1,829 | 2,755* | 5,206 | 3,646 | 7,901 | 768.1* | 6,132.3 |
| Provision for income taxes | 2,018 | 2,651 | -2,687* | 2,759 | 691 | 2,831 | 4,948* | 655 | 866 | 1,690 | 509* | 4,462 | 1,947 | 2,493 | -2,000* | 2,484 | 1,750 | 3,660 | 7,166.3* | 4,009.1 |
| Net loss | -3,571 | -3,767 | -4,641* | -2,941 | -1,270 | -5,420 | -8,201* | -995 | -1,639 | -1,292 | -10,139* | -4,269 | -935 | -664 | 4,755* | 2,722 | 1,896 | 4,241 | -6,398.2* | 2,123.1 |
| Net income (loss) attributable to noncontrolling interests | 18 | 18 | -10* | 7 | -1 | 32 | 3* | 16 | 12 | 6 | 30* | -10 | 23 | -19 | 4* | 16 | 73 | 53 | 110.1* | 103.1 |
| Net loss attributable to common stockholders | -3,589 | -3,785 | -4,631* | -2,948 | -1,269 | -5,452 | -8,204* | -1,011 | -1,651 | -1,298 | -10,169* | -4,259 | -958 | -645 | 4,751* | 2,706 | 1,823 | 4,188 | -6,508.3* | 2,020 |
| Basic (in dollars per share) | -0.01 | -0.01 | -0.01 | 0 | -0.01 | 0 | 0 | -0 | -0.01 | -0 | -0 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
| Diluted (in dollars per share) | -0.01 | -0.01 | -0.01 | 0 | -0.01 | 0 | 0 | -0 | -0.01 | -0 | -0 | 0.01 | 0 | 0.01 | 0.01 | |||||
| Basic (in shares) | 399,597 | 397,450 | 392,613 | 389,903 | 382,557 | 380,599 | 379,514 | 375,211 | 373,081 | 361,261 | 342,794 | 339,025 | 337,497 | 334,762.8 | 329,454.1 | |||||
| Diluted (in shares) | 399,597 | 397,450 | 392,613 | 389,903 | 382,557 | 380,599 | 379,514 | 375,211 | 373,081 | 361,261 | 342,794 | 381,071 | 379,626 | 378,890.4 | 378,934 |